Indeed, the tracheomalacia observed in Rspo2 mutants is made worse with additional reduction in Lrp6. This suggests that a dose-dependent disruption of Wnt activity may severely impact tracheal chondrogenesis (Bell et al., 2008). Here, RSPO2 is linked to Tracheomalacia.